Sign in
4

Changes in Ownership

NextCure, Inc. Filed Acc 0001123292-19-000892

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KABAKOFF DAVID S · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +22,000 22,000 D
Loading xslF345X03/edgar.xml…